We are live on ! Find out more
AV

ASR Vermogensbeheer Portfolio holdings

AUM $8.5B
1-Year Est. Return 25.14%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+25.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.5B
AUM Growth
-$96.1M
Cap. Flow
+$411M
Cap. Flow %
4.83%
Top 10 Hldgs %
34.38%
Holding
534
New
8
Increased
456
Reduced
39
Closed
2

Top Buys

1
AZN icon
AstraZeneca
AZN
+$162M
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$41.2M
3
NVDA icon
NVIDIA
NVDA
+$33.2M
4
UBS icon
UBS Group
UBS
+$19.4M
5
AAPL icon
Apple
AAPL
+$16.9M

Top Sells

1
META icon
Meta Platforms (Facebook)
META
+$17.1M
2
BDX icon
Becton Dickinson
BDX
+$8.94M
3
SLB icon
SLB Ltd
SLB
+$7.67M
4
GIB icon
CGI
GIB
+$4.75M
5
AMAT icon
Applied Materials
AMAT
+$3.24M

Sector Composition

1 Technology 30.92%
2 Financials 13.2%
3 Healthcare 11.8%
4 Consumer Discretionary 10.12%
5 Communication Services 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GIB icon
451
CGI
GIB
$14.3B
$809K 0.01%
11,103
-59,434
-84% -$4.75M
TRI icon
452
Thomson Reuters
TRI
$42B
$789K 0.01%
8,635
– –
ROP icon
453
Roper Technologies
ROP
$36.6B
$782K 0.01%
2,211
+15
+0.7% +$5.53K
GRMN
454
Garmin
GRMN
$48.1B
$767K 0.01%
3,306
+61
+2% +$13.7K
ENTG icon
455
Entegris
ENTG
$21.1B
$756K 0.01%
6,450
+59
+0.9% +$6.97K
IBKR icon
456
Interactive Brokers
IBKR
$40.3B
$726K 0.01%
10,831
+158
+1% +$11.3K
UTHR icon
457
United Therapeutics
UTHR
$22.7B
$724K 0.01%
1,221
+29
+2% +$14.4K
INCY icon
458
Incyte
INCY
$23.4B
$719K 0.01%
7,634
+2,033
+36% +$203K
KIM icon
459
Kimco Realty
KIM
$17.6B
$702K 0.01%
31,235
+421
+1% +$9.28K
ZM icon
460
Zoom
ZM
$26.7B
$657K 0.01%
8,171
+724
+10% +$60.6K
CG icon
461
Carlyle Group
CG
$16.6B
$643K 0.01%
13,281
+179
+1% +$9.87K
ARE icon
462
Alexandria Real Estate Equities
ARE
$8.75B
$635K 0.01%
13,679
+194
+1% +$10.2K
TOST icon
463
Toast
TOST
$17.4B
$624K 0.01%
23,528
+350
+2% +$10.4K
WRB icon
464
W.R. Berkley
WRB
$26.7B
$604K 0.01%
9,115
+200
+2% +$13.8K
SNAP icon
465
Snap
SNAP
$7.62B
$592K 0.01%
128,625
+2,222
+2% +$13.1K
IONQ icon
466
IonQ
IONQ
$13B
$592K 0.01%
20,524
+378
+2% +$14.5K
ALAB icon
467
Astera Labs
ALAB
$52B
$580K 0.01%
5,298
+320
+6% +$45.6K
TW icon
468
Tradeweb Markets
TW
$21.3B
$572K 0.01%
4,865
+90
+2% +$10.3K
VSNT
469
Versant Media Group
VSNT
$5.08B
$556K 0.01%
+15,021
New +$506K
ALLE icon
470
Allegion
ALLE
$11.8B
$556K 0.01%
3,827
+63
+2% +$10K
NBIX icon
471
Neurocrine Biosciences
NBIX
$17.2B
$555K 0.01%
4,210
+75
+2% +$9.95K
ESS icon
472
Essex Property Trust
ESS
$18.8B
$541K 0.01%
2,236
+30
+1% +$7.57K
CNC icon
473
Centene
CNC
$32.8B
$519K 0.01%
15,843
+371
+2% +$15.2K
MGA icon
474
Magna International
MGA
$18.1B
$515K 0.01%
9,249
– –
IT icon
475
Gartner
IT
$9.39B
$510K 0.01%
3,222
+36
+1% +$6.62K
17 18
19
20 21

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return

ASR Vermogensbeheer's Q1 2026 Portfolio in Review

As of Q1 2026, ASR Vermogensbeheer held 534 positions worth $8.5B, down 1.1% from $8.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ASR Vermogensbeheer deployed $411M of net new capital in Q1 2026, opening 8 new positions and adding to 456 existing holdings. Its largest new stake was AstraZeneca: 841,921 shares worth $163M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $17.1M trimmed.

  • ASR Vermogensbeheer's largest Q1 2026 buy was AstraZeneca: 841,921 shares worth $163M.
  • ASR Vermogensbeheer added most to NVIDIA in Q1 2026, an estimated $33.2M increase.
  • ASR Vermogensbeheer's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $17.1M.
  • ASR Vermogensbeheer fully exited Amrize Ltd in Q1 2026, selling an estimated $1.58M.
  • ASR Vermogensbeheer's ten largest holdings make up 34% of its $8.5B portfolio in Q1 2026.
  • ASR Vermogensbeheer opened 8 new positions and closed 2 in Q1 2026.
  • ASR Vermogensbeheer's portfolio value fell 1.1% quarter-over-quarter to $8.5B.

Based on ASR Vermogensbeheer's 13F filing for Q1 2026, filed 30 Apr 2026.